Appendix Table 5.
Baseline | Follow-up | Absolute Change | |
---|---|---|---|
Age | 53.6 years | ||
Disease duration (months) | 43.3 | ||
Global assessments | |||
Patient global assessment (0–10)* | 1 | 2 | 1 |
Physician global assessment (0–10)* | 1 | 2 | 1 |
Musculoskeletal | |||
HAQ-DI (0–3)* | 0 | 0 | 0 |
Tendon friction rubs* | No | Yes | Change to worsen |
Skin | |||
MRSS (0–51)* | 7 | 5 | −2 |
Patient skin interference last month | 3 | 2 | −1 |
Lung | |||
FVC% predicted* | 87 | 80 | −7 |
Breathing VAS (0–10) | 0 | 1 | 1 |
Renal | |||
Renal crisis** | No | No | No change |
Gastrointestinal | |||
GI VAS (0–10) | 0 | 1 | 1 |
Body Mass Index (BMI) | 24.68 | 24.68 | 0 |
Raynaud’s | |||
Raynaud’s VAS (0–10) | 0 | 3 | 3 |
Digital ulcers | |||
Digital ulcers VAS (0–10) | 0 | 0 | 0 |
Number of digital ulcers | 0 | 0 | 0 |
HRQOL | |||
Pain VAS (0–10) | 1 | 1 | 0 |
Fatigue (SF-36 Vitality scale) (0–100) | 37.52 | 35.10 | −2.42 |
included in Step 2;
included in Step 1
HAQ-DI= health assessment questionnaire-disability index, MRSS= modified Rodnan skin score, FVC= Forced vital capacity, GI= gastrointestinal, VAS= visual analog scale